Insight Pharma Affiliated Reports Collection Announces Respiratory Distress Syndrome Report

Respiratory Distress Syndrome – Pipeline Review Report - This report provides information on the therapeutic development for Respiratory Distress Syndrome, complete with latest updates, and special features on late-stage and discontinued projects.
By: Insight Pharma
 
April 5, 2012 - PRLog -- NEEDHAM, MASS. – Cambridge Healthtech Institute’s Insight Pharma Affiliated Reports Collection announces the Respiratory Distress Syndrome – Pipeline Review Report, published by Global Business Intelligence.

This report provides information on the therapeutic development for Respiratory Distress Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Respiratory Distress Syndrome.


Scope of the report:


      • A snapshot of the global therapeutic scenario for Respiratory Distress Syndrome.
      • A review of the Respiratory Distress Syndrome products under development by     companies and universities/research institutes based on information derived from company and industry-specific sources.
      • Coverage of products based on various stages of development ranging from discovery till registration stages.
      • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
      • Coverage of the Respiratory Distress Syndrome pipeline on the basis of route of administration and molecule type.
      • Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
      • Key discontinued pipeline projects.
      • Latest news and deals relating to the products.

For more information and to purchase this Insight Pharma Report, visit: http://www.InsightPharmaReports.com

About Insight Pharma Reports

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://www.InsightPharmaReports.com

Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/affiliatedreports/

# # #

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets.
End
Source:Insight Pharma
Email:***@healthtech.com Email Verified
Zip:02494
Tags:Market Report, Big Pharma, Biotech, Pharmaceutical, R D, Reports, Respiratory Distress Syndrome
Industry:Biotech, Reports, Science
Location:Needham - Massachusetts - United States
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Insight Pharm Reports PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share